Ki67 Proliferation in Core Biopsies Versus Surgical Samples - A Model for Neo-Adjuvant Breast Cancer Studies

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-341
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Redox Imaging of Human Breast Cancer Core Biopsies

Academic Radiology
Nuclear MedicineRadiologyImaging
2013English

CRITICS-II: A Multicentre Randomised Phase II Trial of Neo-Adjuvant Chemotherapy Followed by Surgery Versus Neo-Adjuvant Chemotherapy and Subsequent Chemoradiotherapy Followed by Surgery Versus Neo-Adjuvant Chemoradiotherapy Followed by Surgery in Resectable Gastric Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Assessment of Ki67 in Breast Cancer: Recommendations From the International Ki67 in Breast Cancer Working Group

Journal of the National Cancer Institute
Cancer ResearchOncology
2011English

Morphological Estimation of Cellularity on Neo-Adjuvant Treated Breast Cancer Histological Images

2020English

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Cognitive Dysfunction Following Adjuvant Chemotherapy for Breast Cancer: Two Case Studies

Oncology Nursing Forum
Oncology
2003English

Clinicopathological Evaluation of Neo-Adjuvant Chemotherapy With Paclitaxel Followed by Fec for Locally Advanced Breast Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2005English

Ki67 Is a Graded Rather Than a Binary Marker of Proliferation Versus Quiescence

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Clinical Studies of Apoptosis and Proliferation in Breast Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy